Find NINDS Clinical Trials

Study Title Disorders Status Study Location Clinical Trials ID
An Open-Label Maintenance Study of the Enzyme Replacement Therapy Replagal in Patients With Fabry Disease Fabry Disease Completed Maryland NCT00357786
An Open-Label Clinical Trial of Replagal Enzyme Therapy in Children Ages 7-17 Years With Fabry Disease Fabry Disease Completed Maryland NCT00071877
An Open Label Dose Escalation Safety Study of Convection-Enhanced Delivery of IL13-PE38QQR in Patients With Progressive Pediatric Diffuse Infiltrating Brainstem Glioma and Supratentorial High-grade Glioma Terminated Maryland NCT00880061
An Observational Study of Neurologic Function After COVID-19 Infection Recruiting Maryland* NCT04564287
An MRI Ancillary Study of a Malaria Fever Investigation Enrolling by Invitation NCT05746819
An Internet-based Program to Help Cancer Survivors Manage Pain Recruiting Multiple U.S. Locations NCT04462302
An Extension Study to Assess Vamorolone in Boys With Duchenne Muscular Dystrophy (DMD) Completed Multiple U.S. Locations NCT02760277
An Analysis of the Symptomatic Domains Most Relevant to Charcot Marie Tooth Neuropathy (CMT) Patients Completed Florida NCT02429947
Amlodipine Plus Botulinum Toxin for Focal Dystonia Completed Maryland NCT00015457
AMES Treatment of the Impaired Leg in Chronic Stroke Patients Stroke Multiple U.S. Locations NCT01378637
AMES + Brain Stimulation Stroke Oregon NCT01169181
Amantadine for Neuroenhancement in Acute Patients Study Not Yet Recruiting NCT05479032
Alternative Dosing and Regimen of Replagal to Treat Fabry Disease Fabry Disease Completed Maryland NCT00075244
ALteplase in Patients With LOW NIHSS and Specified Disabling Deficits Not Yet Recruiting NCT06115070
Alpha-Galactosidase A Replacement Therapy for Fabry Disease Fabry Disease Completed Maryland NCT00048906
Alpers Huttenlocher Natural History Study Multiple U.S. Locations NCT03034512
Aloxi for Prevention of Chemotherapy Induced Nausea and Vomiting in Malignant Glioma Patients Receiving Irinotecan With Bevacizumab Terminated North Carolina NCT00636805
Alemtuzumab to Treat Sporadic Inclusion Body Myositis Completed Maryland NCT00079768
Albumin in Acute Ischemic Stroke Trial Terminated Multiple U.S. Locations NCT00235495
ALA-induced PpIX Fluorescence During Brain Tumor Resection Active, Not Recruiting New Hampshire NCT02191488